| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Journal of Clinical Endocrinology & Metabolism, Vol 80, 654-658, Copyright © 1995 by Endocrine Society
ARTICLES |
R Pasquali, F Casimirri, R De Iasio, P Mesini, S Boschi, R Chierici, R Flamia, M Biscotti and V Vicennati
Institute of Clinical Medicine 1, Endocrine Unit, Bologna, Italy.
There are no studies in vivo on the effects of insulin on androgens and sex hormone-binding globulin (SHBG) in men. We, therefore, investigated the effects of insulin suppression on testosterone and SHBG in two groups of eight nondiabetic adult obese men and six healthy normal weight men who underwent diazoxide treatment (100 mg, three times daily) for 7 days. Blood samples for hormone determination were obtained before the subjects had been selected for the study, immediately before diazoxide administration, and on the last day of treatment. A 24-h oral glucose tolerance test was also performed for glucose, insulin, and C-peptide determinations before and on the last day of treatment. Only one subject experienced significant side- effects, and no significant changes in mean body weight were found during the treatment. Diazoxide administration worsened glucose tolerance in several subjects and reduced fasting and glucose- stimulated insulin levels by approximately 50% in both control and obese subjects. No significant difference was present between historical and pretreatment hormone values in either group. Moreover, there were no differences in pretreatment gonadotropin and SHBG concentrations between the two groups, whereas testosterone (free and total) levels were lower in the obese than in the control subjects. After diazoxide administration, testosterone (free and total) decreased slightly, but significantly, whereas LH and SHBG significantly increased in both groups. Diazoxide treatment increased estradiol levels in controls, but not in obese men. In conclusion, these results indicate that in vivo, insulin is capable of stimulating testosterone production and, simultaneously, of inhibiting SHBG concentrations in both normal weight and obese men.
This article has been cited by other articles:
![]() |
M. A. Lawson, S. Jain, S. Sun, K. Patel, P. J. Malcolm, and R. J. Chang Evidence for Insulin Suppression of Baseline Luteinizing Hormone in Women with Polycystic Ovarian Syndrome and Normal Women J. Clin. Endocrinol. Metab., June 1, 2008; 93(6): 2089 - 2096. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. S. Kasturi, J. Tannir, and R. E. Brannigan The Metabolic Syndrome and Male Infertility J Androl, May 1, 2008; 29(3): 251 - 259. [Abstract] [Full Text] [PDF] |
||||
![]() |
R J. Barnard Prostate cancer prevention by nutritional means to alleviate metabolic syndrome Am. J. Clinical Nutrition, September 1, 2007; 86(3): 889S - 893S. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. B. Araujo, V. Kupelian, S. T. Page, D. J. Handelsman, W. J. Bremner, and J. B. McKinlay Sex Steroids and All-Cause and Cause-Specific Mortality in Men Arch Intern Med, June 25, 2007; 167(12): 1252 - 1260. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A Mohr, S. Bhasin, C. L Link, A. B O'Donnell, and J. B McKinlay The effect of changes in adiposity on testosterone levels in older men: longitudinal results from the Massachusetts Male Aging Study Eur. J. Endocrinol., September 1, 2006; 155(3): 443 - 452. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Tomar, S. Dhindsa, A. Chaudhuri, P. Mohanty, R. Garg, and P. Dandona Contrasting Testosterone Concentrations in Type 1 and Type 2 Diabetes Diabetes Care, May 1, 2006; 29(5): 1120 - 1122. [Full Text] [PDF] |
||||
![]() |
V. Kupelian, S. T. Page, A. B. Araujo, T. G. Travison, W. J. Bremner, and J. B. McKinlay Low Sex Hormone-Binding Globulin, Total Testosterone, and Symptomatic Androgen Deficiency Are Associated with Development of the Metabolic Syndrome in Nonobese Men J. Clin. Endocrinol. Metab., March 1, 2006; 91(3): 843 - 850. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Reinehr, G. de Sousa, C. L. Roth, and W. Andler Androgens before and after Weight Loss in Obese Children J. Clin. Endocrinol. Metab., October 1, 2005; 90(10): 5588 - 5595. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Muller, D. E. Grobbee, I. den Tonkelaar, S. W. J. Lamberts, and Y. T. van der Schouw Endogenous Sex Hormones and Metabolic Syndrome in Aging Men J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 2618 - 2623. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Pitteloud, M. Hardin, A. A. Dwyer, E. Valassi, M. Yialamas, D. Elahi, and F. J. Hayes Increasing Insulin Resistance Is Associated with a Decrease in Leydig Cell Testosterone Secretion in Men J. Clin. Endocrinol. Metab., May 1, 2005; 90(5): 2636 - 2641. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Laaksonen, L. Niskanen, K. Punnonen, K. Nyyssonen, T.-P. Tuomainen, V.-P. Valkonen, and J. T. Salonen The Metabolic Syndrome and Smoking in Relation to Hypogonadism in Middle-Aged Men: A Prospective Cohort Study J. Clin. Endocrinol. Metab., February 1, 2005; 90(2): 712 - 719. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Laaksonen, L. Niskanen, K. Punnonen, K. Nyyssonen, T.-P. Tuomainen, V.-P. Valkonen, R. Salonen, and J. T. Salonen Testosterone and Sex Hormone-Binding Globulin Predict the Metabolic Syndrome and Diabetes in Middle-Aged Men Diabetes Care, May 1, 2004; 27(5): 1036 - 1041. [Abstract] [Full Text] [PDF] |
||||
![]() |
P.-S. Leung, W. J. Aronson, T. H. Ngo, L. A. Golding, and R. J. Barnard Exercise alters the IGF axis in vivo and increases p53 protein in prostate tumor cells in vitro J Appl Physiol, February 1, 2004; 96(2): 450 - 454. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Muller, Y. T. van der Schouw, J. H. H. Thijssen, and D. E. Grobbee Endogenous Sex Hormones and Cardiovascular Disease in Men J. Clin. Endocrinol. Metab., November 1, 2003; 88(11): 5076 - 5086. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. W.C.M. van Dam, J. M. Dekker, E. G.W.M. Lentjes, F. P.T.H.M. Romijn, Y. M. Smulders, W. J. Post, J. A. Romijn, and H. M. J. Krans Steroids in Adult Men With Type 1 Diabetes: A tendency to hypogonadism Diabetes Care, June 1, 2003; 26(6): 1812 - 1818. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Fukui, Y. Kitagawa, N. Nakamura, M. Kadono, S. Mogami, C. Hirata, N. Ichio, K. Wada, G. Hasegawa, and T. Yoshikawa Association Between Serum Testosterone Concentration and Carotid Atherosclerosis in Men With Type 2 Diabetes Diabetes Care, June 1, 2003; 26(6): 1869 - 1873. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Lacaille, P. Julien, Y. Deshaies, C. Lavigne, L.-D Brun, and H. Jacques Responses of Plasma Lipoproteins and Sex Hormones to the Consumption of Lean Fish Incorporated in a Prudent-Type Diet in Normolipidemic Men J. Am. Coll. Nutr., June 1, 2000; 19(6): 745 - 753. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Friedl, R. J. Moore, R. W. Hoyt, L. J. Marchitelli, L. E. Martinez-Lopez, and E. W. Askew Endocrine markers of semistarvation in healthy lean men in a multistressor environment J Appl Physiol, May 1, 2000; 88(5): 1820 - 1830. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Isidori, M. Caprio, F. Strollo, C. Moretti, G. Frajese, A. Isidori, and A. Fabbri Leptin and Androgens in Male Obesity: Evidence for Leptin Contribution to Reduced Androgen Levels J. Clin. Endocrinol. Metab., October 1, 1999; 84(10): 3673 - 3680. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |